Effects of rhinacanthin-C on function and expression of drug efflux transporters in Caco-2 cells

Fitoterapia

Volumn 89, Issue 1, 2013, Pages 80-85

  Wongwanakul, Ratjika ^a   Vardhanabhuti, Nontima ^a   Siripong, Pongpun ^b   Jianmongkol, Suree ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NATIONAL CANCER INSTITUTE   (Thailand)

Author keywords

Caco 2 cells; MRP2; Naphthoquinone; P glycoprotein; Rhinacanthin C

Indexed keywords

CALCEIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 2; NAPHTHOQUINONE; RHINACANTHIN C; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN CACO 2; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ACANTHACEAE; RHINACANTHUS NASUTUS;

EID: 84885140017     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2013.05.019     Document Type: Article

References (43)

1. Fromm MF. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 2004;25:423-9. (Pubitemid 38981558)
2. Glavinas H, Krajcsi P, Cserepes J, Sarkadi B. The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv 2004;1:27-42.
3. Leslie EM, Deeley RG, Cole SPC. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 2005;204:216-37. (Pubitemid 40552845)
4. Takano M, Yumoto R, Murakami T. Expression and function of efflux drug transporters in the intestine. Pharmacol Ther 2006;109:137-61. (Pubitemid 41740818)
5. Fletcher Jl, Haber M, Henderson MJ, Norris MD. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer 2010;10:147-56.
6. Avendaño C, Menéndez JC. Inhibitors of multidrug resistance to antitumor agents (MDR). Curr Med Chem 2002;9:159-93. (Pubitemid 34436440)
7. Seelig A. A general pattern for substrate recognition by P-glycoprotein. Eur J Biochem 1998;251:252-61. (Pubitemid 28081437)
8. Sharom FJ, Liu R, Romsicki Y, Lu P. Insight into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies. Biochim Biophys Acta 1999;1461:327-45.
9. Marchetti S, Mazzanti R, Beijnen JH, Schellens JHM. Concise review: clinical relevance of drug-drug and herb-drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist 2007;12:927-41. (Pubitemid 47359135)
10. Lim S, Grassi J, Akhmedjanova V, Debiton E, Balansard G, Beliveau R, Barthomeuf C. Reversal of P-glycoprotein-mediated drug efflux by eudesmin from Haplophyllum perforatum and cytotoxicity pattern versus diphyllin, podophyllotoxin and etoposide. Planta Med 2007;73:1563-7.
11. Yoo HH, Lee M, Lee MW, Lim SY, Shin J, Kim DH. Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 cells. Planta Med 2007;73:444-50. (Pubitemid 46917459)
12. Sukhaphirom N, Vardhanabhuti N, Chirdchupunseree H, Pramyothin P, Jianmongkol S. Phyllanthin and hypophyllanthin inhibit function of P-gp but not MRP2 in Caco-2 cells. J Pharm Pharmacol 2013;65:292-9.
13. Morris ME, Zhang S. Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Life Sci 2006;78:2116-30.
14. Matsson P, Pedersen JM, Norinder U, Bergstrom CAS, Artursson P. Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs. Pharm Res 2009;26:1816-31.
15. Johne A, Brockmoller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999;66:338-45. (Pubitemid 29494126)
16. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John's wort. Lancet 2000;355:547-8. (Pubitemid 30088677)
17. Perloff MD, von Moltke LL, Stormer E, Shader RI, Greenblatt DJ. Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br J Pharmacol 2001;134:1601-8. (Pubitemid 34038092)
18. Veneroni S, Zaffaroni N, Daidone MG, Benini E, Villa R, Silvestrini R. Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers. Eur J Cancer 1994;30:1002-7. (Pubitemid 24256252)
19. Demeule M, Brossard M, Beliveau R. Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. Am J Physiol Renal Physiol 1999;277:832-40.
20. Hinoshita E, Uchiumi T, Taguchi K, Kinukawa N, Tsuneyoshi M, Maehara Y, Sugimachi K, Kuwano M. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin Cancer Res 2000;6:2401-7. (Pubitemid 30399208)
21. Wutthithamavet W. Thai traditional medicine. revised ed.Bangkok: Odean Store Press; 1997 314.
22. Farnsworth NR, Bunyapraphatsara N. Thai medicinal plant: recommended for primary health care system. Bangkok: Prachachon Company; 1992.
23. Siripong P, Kanokmedakul K, Piyaviriyagul S, Yahuafai J, Chanpai R, Ruchirawat S, Oku N. Antiproliferative naphthoquinone esters from Rhinacanthus nasutus Kurz. roots on various cancer cells. J Trad Med 2006;23:166-72.
24. Siripong P, Yahuafai J, Shimizu K, Ichikawa K, Yonezawa S, Asai T, Kanokmedakul K, Ruchirawat S, Oku N. Induction of apoptosis in tumor cells by three naphthoquinone esters isolated from Thai medicinal plant: Rhinacanthus nasutus Kurz. Biol Pharm Bull 2006;29:2070-6. (Pubitemid 44510811)
25. Tewtrakul S, Tansakul P, Panichayupakaranant P. Effects of rhinacanthins from Rhinacanthus nasutus on nitric oxide, prostaglandin E2 and tumor necrosis factor-alpha releases using RAW264.7 macrophage cells. Phytomedicine 2009;16:581-5.
26. Sendl A, Chen JL, Jolad SD, Stoddart C, Rozhon E, Kernan M, Nanakorn W, Balick M. Two new naphthoquinones with antiviral activity from Rhinacanthus nasutus. J Nat Prod 1996;59:808-11. (Pubitemid 26299177)
27. Gotoh A, Sakaeda T, Kimura T, Shirakawa T, Wada Y, Wada A, Kimachi T, Takemoto Y, Iida A, Iwakawa S, Hirai M, Tomita H, Okamura N, Nakamura T, Okumura K. Antiproliferative activity of Rhinacanthus nasutus (L.) Kurz extracts and the active moiety, rhinacanthin C. Biol Pharm Bull 2004;27:1070-4. (Pubitemid 41701761)
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63. (Pubitemid 14203433)
29. Essodaigui M, Broxterman HJ, Garnier-Suillerot A. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry 1998;37:2243-50. (Pubitemid 28119297)
30. Breeuwer P, Drocourt JL, Bunschoten N, Zwietering MH, Rombouts FM, Abee T. Characterization of uptake and hydrolysis of fluorescein diacetate and carboxyfluorescein diacetate by intracellular esterases in Saccharomyces cerevisiae, which result in accumulation of fluorescent product. Appl Environ Microbiol 1995;61:1614-9.
31. Silva R, Carmo H, Dinis-Oliveira R, Cordeiro-da-Silva A, Lima SC, Carvalho F, Bastos MDL, Remiao F. In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells. Arch Toxicol 2011;85:315-26.
32. Pedersen JM, Matsson P, Bergstrom CAS, Norinder U, Hoogstraate J, Artursson P. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). J Med Chem 2008;51:3275-87. (Pubitemid 351821886)
33. Wongwanakul R, Vardhanabhuti N, Jianmongkol S. Effects of rhinacanthin-N on efflux drug transporters in the Caco-2 cells. Thai J Pharmacol 2012;34: 183-9.
34. Kawada M, Umezawa K. Inostamycin, an inhibitor of P-glycoprotein function, interacts specifically with phosphatidylethanolamine. Jpn J Cancer Res 1995;86:873-8.
35. Yang JM, Sullivan GF, Makhey DB, Lavoie EJ, Hait WN. Inhibitory effect of alkylating modulators on the function of P-glycoprotein. Oncol Res 1997;9:477-84. (Pubitemid 127825999)
36. Hunter J, Jepson MA, Tsuruo T, Simmons NL, Hirst BH. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J Biol Chem 1993;268:14991-7. (Pubitemid 23206648)
37. Maitra R, Halpin PA, Karlson KH, Page RL, Paik DY, Leavitt MO, Moyer BD, Stanton BA, Hamilton JW. Differential effects of mitomycin C and doxorubicin on P-glycoprotien expression. Biochem J 2001;355:617-24. (Pubitemid 32434077)
38. Han Y, Tan TMC, Lim LY. Effects of capsaicin on P-gp function and expression in Caco-2 cells. Biochem Pharmacol 2006;71:1727-34. (Pubitemid 43732499)
39. Han Y, Tan TMC, Lim LY. In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression. Toxicol Appl Pharmacol 2008;230:283-9.
40. Hou XL, Takahashi K, Tanaka K, Tougou K, Qiu F, Komatsu K, Takahashi K, Azuma J. Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways. Int J Pharm 2008;358:224-9.
41. Shirasaka Y, Kawasaki M, Sakane T, Omatsu H, Moriya Y, Nakamura T, Sakaeda T, Okumura K, Langguth P, Yamashita S. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport. Drug Metab Pharmacokinet 2006;21:414-23.
42. Zrieki A, Farinotti R, Buyse M. Cyclooxygenase Inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line. Pharm Res 2008;25: 1991-2001.
43. Hosoya KI, Kim KJ, Lee VHL. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers. Pharm Res 1996;13:885-90. (Pubitemid 26227764)